MedTrace Logo

Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma

NCT02177552 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2019-02-15

No results posted yet for this study

Summary

The main purpose of this study is to determine the effects of treatment with carboplatin, docetaxel and capecitabine in patients with incurable cancer of the esophagus or stomach.

Conditions

  • Esophageal Neoplasms
  • Stomach Neoplasms

Interventions

DRUG

Carboplatin

DRUG

Docetaxel

DRUG

Capecitabine

DRUG

Epirubicin

DRUG

Oxaliplatin

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Peter C Petersen, MD · Finsen Center, Rigshospitalet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2019-08-31
Completion
2019-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02177552 on ClinicalTrials.gov